- Compound
- CDB005285 (Pyridoxine)
- Term
- Muscle weakness
- Definition
- A disorder characterized by a reduction in the strength of the muscles. (nci ctcae).
- Parent Term
- Musculoskeletal and connective tissue disorders
- Parent Definition
- Any disorder (non-neoplastic or neoplastic) that affects muscles, bones and other connective tissue.
- Other Compounds Mapped to 'Muscle weakness'
CDB006168 (Tyramine)CDB000058 (Benzyl acetate)CDB000514 (2-Methylpentane)CDB000532 (3-Methylpentane)CDB000559 (o-Xylene)CDB000564 (Benzophenone)CDB000580 (Carbofuran)CDB000657 (p-Xylene)CDB000673 (Toluene)CDB000722 (m-Xylene)References